Taichi Mizushima

ORCID: 0000-0002-3505-4717 · 4 papers in corpus
2025
Assessment of tissue factor pathway inhibitor 2 (TFPI2) as a novel serum marker for malignant tumors of the ovary before and after treatment: A case-control study.
The journal of obstetrics and gynaecology research ·doi:10.1111/jog.16241

AimTissue factor pathway inhibitor 2 (TFPI2) is a preoperative biomarker that was developed to discriminate ovarian benign tumors from cancer and is covered by health insurance in Japan. The purpose of this study was to evaluate how the TFP…

article 2022
Vaginal stump endometriosis following total laparoscopic hysterectomy: A case report
·doi:10.5180/jsgoe.38.2_235

A 40-year-old G0P0 presented with uterine leiomyomas and underwent total laparoscopic hysterectomy and bilateral salpingectomy for management of worsening hypermenorrhea. Intraperitoneal findings included an endometriotic lesion (approximat…

2019
The Role of Androgen Receptor Signaling in Ovarian Cancer.
Cells ·doi:10.3390/cells8020176

Emerging evidence has suggested that androgen receptor signaling plays an important role in ovarian cancer outgrowth. Specifically, androgen receptor activation appears to be associated with increased risks of developing ovarian cancer and …

article 2013
Evaluating the risk factors for developing resistance to parenteral therapy for tubo‐ovarian abscess: A case–control study
·doi:10.1111/jog.12018

AIM: The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo-ovarian abscesses (TOA). MATERIAL AND METHODS: We conducted a case-control study involving 55 admitted patients w…